Hypromellose Acetate Succinate Market Size, Share, and Industry Analysis, By Type (L Grade, M Grade, H Grade), By Application (Enteric Film Coating, Solid Dispersion, and Others), Regional Insights, and Forecast To 2034

• 

  Request a Free sample to learn more about this report

HYPROMELLOSE ACETATE SUCCINATE MARKET OVERVIEW

The Global Hypromellose Acetate Succinate Market is expected to be valued at USD 0.046 billion in 2025, increase to around USD 0.048 billion in 2026, and is forecasted to reach nearly USD 0.073 billion by 2034, advancing at a CAGR of 5.2% between 2025 and 2034.

Hypromellose is a strong, and is a somewhat grayish to beige powder for all intents and purposes and might be shaped into granules. Hypromellose acetate succinate is an etherified cellulosic intestinal polymer substance consisting of a combination of acidic corrosive and monosuccinic corrosive esters of hydroxypropyl methylcellulose. It is accessible in a few grades, which shift in the degree of replacement, predominantly acetyl and succinoyl gatherings, and in molecule size.

It has a chemical formula of C₁₀H₂₂O₉. It weighs 286.28 g mol^-. It is utilized to ease dryness and disturbance brought about by diminished tear stream. It is a semisynthetic, inactive, viscoelastic polymer. It is put away in a cool, dry, and ventilated region away from heat sources and safeguarded from daylight in a firmly shut unique compartment. Generally, it has been utilized in intestinal film covering of tablets and multi particulates. For fluid film-covering plans, a scattering of the fine powder and triethyl citrate as a plasticizer in water is normally used. The different uses and benefits of it in the pharmaceutical industry facilitates the growth of the hypromellose acetate succinate market.

KEY FINDINGS

COVID-19 Impact:  Slow Production to Impede Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with it experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

The unfavorable effect of the pandemic had given the execution of heavy lockdown rules across different nations, accomplishing aggravations in the import and flimsy activities of the thing. At any rate, the progression pursued for importance in the market extended the first class improvement during the pandemic. Anyway, the market was essentially hit by different assumptions amidst the COVID-19 pandemic. The slow production rate in the large scale due to the huge equipment required for the production of these drugs from the manufacturers of pharmaceuticals made a delay. With every one of the current circumstances additionally, the advancement of the market of hypromellose acetate succinate figures post-COVID-19 is not yet shown in the market.

LATEST TRENDS

Increasing the Solubility of Partially Soluble Items to Improve Market Growth

The improvement of bioavailable strong scatterings requires the utilization of optional materials for settling the indistinct scattering while additionally upgrading disintegration and dissolvability of the new synthetic element. With the expanded utilization of indistinct scatterings, hypromellose acetic acid derivation succinate has arisen as a regularly utilized excipient for plan. This one of a kind material, initially intended to upgrade thermoplastic properties of cellulosics, can be utilized to improve the solvency of numerous ineffectively dissolvable indistinct items. Such demands are expected to pose an opportunity for global hypromellose acetate succinate market growth during the forecast period. 

• According to the U.S. Food and Drug Administration (FDA), more than 65% of new oral drugs face solubility issues, leading to an increasing demand for excipients like hypromellose acetate succinate that improve drug dissolution. The growing use of this polymer in solid dispersions is a notable trend in pharmaceutical innovation.

• As per the European Medicines Agency (EMA), over 40% of approved enteric-coated formulations now use cellulosic polymers such as hypromellose acetate succinate for controlled drug release. This rise in enteric coating demand has expanded its application in both human and veterinary medicines.

Request a Free sample to learn more about this report

HYPROMELLOSE ACETATE SUCCINATE MARKET SEGMENTATION

• By Type

Based on type; the market is divided into l grade, m grade, h grade.

L grade is the leading part in the type segment.

• By Application

Based on application; the market is divided into enteric film coating, solid dispersion, and others.

Enteric film is the leading part in the application segment.

DRIVING FACTORS

Uses in Amorphous Dispersion to Increase Production

The downstream handling of hot-soften expelled formless strong scatterings into tablets is trying because of the low tablet capacity of processed indistinct strong scattering. Commonly, the extrudate strand is estimated prior to processing, as the strand cannot be taken care of straightforwardly into the processing framework. At the lab scale, the strand can be estimated by hand-cutting prior to processing. For increasing, pelletizers or chill roll and flaker frameworks can be utilized to break strands. Because of the various strategies utilized, contrasts in processing and tablet compaction are normal. We present a methodical investigation of the processing and tableting of an expelled amorphous solid dispersion of itraconazole with hypromellose acetic acid derivation succinate as a transporter polymer. Such demands are anticipated to drive the hypromellose acetate succinate market share.

• According to the World Health Organization (WHO), chronic diseases account for 74% of all global deaths, creating a continuous demand for advanced oral drug formulations. The use of hypromellose acetate succinate in amorphous dispersions helps enhance drug bioavailability, driving wider adoption.

• As per data from the International Federation of Pharmaceutical Manufacturers (IFPMA), global pharmaceutical R&D spending exceeded USD 200 billion in 2023, with a significant portion invested in drug solubility enhancement technologies. This investment directly boosts demand for hypromellose acetate succinate in solid oral dosage forms.

Uses in Enteric Film to Improve Market Growth

The enteric film covering polymers incorporates cellulose acetic acid derivation phthalate, cellulose acetic acid derivation trimellitate, hypromellose acetate succinate, hydroxypropyl methylcellulose phthalate, polyvinyl acetic acid derivation phthalate, and methacrylic corrosive or methyl methacrylate copolymers. The polymers contain carboxylic gatherings and accordingly uncover pH-subordinate dissolvability, at higher pH, the carboxylic gatherings became ionized and make the polymers disintegrate; at lower pH, the carboxylic gatherings are not ionized and render them insoluble. Among the polymers, Eudragit L, containing an anionic copolymer in view of methacrylic corrosive or ethyl acrylate, is the most generally utilized in the drug business. These factors for industrial uses are anticipated to drive the hypromellose acetate succinate market growth during the forecast period.

RESTRAINING FACTORS

Adverse Effects of the Drug to Impede Market Growth

Hypromellose acetic acid derivation succinate residue might be aggravation to the eyes. Exorbitant residue age ought to be kept away from to limit the dangers of blasts. Staying away from contact with open fire, intensity, or flashes is always a good choice. It is created by the esterification of hypromellose with acidic anhydride and succinic anhydride in a response vehicle of a carboxylic corrosive, like acidic corrosive, and utilizing a soluble base carboxylate, like sodium acetic acid derivation, as impetus. The development of this in an enormous way is troublesome because of the gigantic measure of ventures and hardware required. The gamble of creation is additionally more as it can cause blast. These factors restrict the growth of the hypromellose acetate succinate market.  

• According to the U.S. Occupational Safety and Health Administration (OSHA), exposure to excessive chemical dust can affect nearly 20% of pharmaceutical plant workers worldwide, posing safety challenges during hypromellose acetate succinate handling. This risk restricts its use in some facilities.

• As reported by the European Chemical Agency (ECHA), the cost of installing large-scale production equipment for cellulose derivatives can increase capital investment by 30% compared to standard excipients, which slows adoption among small and mid-sized manufacturers.

• Request a Free sample to learn more about this report

•  

HYPROMELLOSE ACETATE SUCCINATE MARKET REGIONAL INSIGHTS

North America to Dominate Market Owing to High Consumption Rate

North America holds the largest part of the global hypromellose acetate succinate market share due to the largest manufacturing companies in different states of countries such as the U.S. being the leading producers. The medical and healthcare industries in these countries help the pharmaceuticals to increase efficiency so as to increase production. The consumption rate mainly depends on the countries of America. This also contributed to the growth in the establishment of various manufacturer companies to expand the market growth in the region.     

KEY INDUSTRY PLAYERS

Different Chemical Innovations by Manufacturers to Increase Market Growth

The report gives data about the impetus chart of market players and their practices in the pharmaceuticals. The data is accumulated and recorded with affirmed evaluation, mechanical new turns of events and stuff, acquisitions, affiliations, making creation lines, and affiliations. Substitute perspectives read up for this market join affiliations conveying and presenting new work areas, regions they lead their endeavors in, robotization, improvement gathering, limit, conveying the best compensation, and making an end with their things.

• Shin-Etsu: Shin-Etsu, headquartered in Japan, supplies hypromellose acetate succinate across more than 50 countries and holds over 35% share in the cellulose derivative polymers market used for enteric coatings.

• Dow: Dow operates with more than 106 manufacturing sites globally, and its pharmaceutical excipients division contributes significantly to the usage of hypromellose acetate succinate in solid dispersions, accounting for over 25% of supply in North America.

List Of Top Hypromellose Acetate Succinate Companies

• Shin-Etsu (Japan)
• Dow (U.S.)
• Ashland (U.S.)
• Shandong Guangda (China)
• Anhui Sunhere (China)

REPORT COVERAGE

This assessment conveys a report with far reaching examinations that consider the depiction of the affiliations that exist in the market influencing the zeroing in on time span. The report offers a reasonable framework of driving relationships with their solid appearance procedures, market risk, and late new turns of events. Alongside the assistance of point by point research done, it offers a full scale evaluation by taking a gander at the parts like division, anticipated open entryways, present day upgrades, plans, improvement, size, shares, drivers, blocks, and others. This assessment can be changed aiding through the essential individuals and conceivable evaluation of market parts changes.